A phase I study of the MDM2 inhibitor AMG 232 in patients...

European Journal of Cancer 2016 / 12 Vol. 69

A phase I study of the MDM2 inhibitor AMG 232 in patients with advanced p53 wild type (p53WT) solid tumors or multiple myeloma

Langenberg, M.H., Gluck, L., Weger, V., Frank, R., Eskens, F., Blay, J.Y., Soria, J.C., Chawla, S., Gounder, M., Wagner, A., Zhang, Y., Kambuj, P., Loberg, R., Henary, H.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
69
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)32682-x
Date:
December, 2016
File:
PDF, 48 KB
english, 2016
Conversion to is in progress
Conversion to is failed